NASDAQ

SDGR

Schrodinger, Inc.

☾After Hours +1.17 (+4.10%)Nov 4, 7:59 PM ET

At close $28.55 · +1.37 (+5.06%)

Mkt Cap
$2.1B
Volume
1.5M
52W High
$33.78
52W Low
$10.95
PE Ratio
—
Avg Vol
2.4M
As of 11/3/26
Div Yield
—
Beta
1.76
As of 11/3/26

Company

Headquarters
New York, NY
Employees
850 (2026)
Listed
Feb 6, 2020
Exchange
Nasdaq
SEC industry
Pharmaceutical Preparations

Pharmaceuticals

  • Market cap #84 of 430
  • P/B #65 of 396

Ranked highest first among stocks Cylvex covers.

  1. LLYEli Lilly and Company$1.26T+0.60%
  2. JNJJohnson & Johnson$665.3B+3.83%
  3. ABBVAbbVie Inc$520.9B+3.07%
  4. MRKMerck & Co Inc$370.9B+3.91%
  5. NVSNovartis AG$311.6B+3.60%
All Pharmaceuticals ›

Financial summary

Related companies

About

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

From company filings and market data · Not investment advice

Price data

Day Low $26.23Day High $28.69
52W Low $10.9552W High $33.78
Open
$27.20
Prev Close
$27.18
Volume
1.5M
Avg Vol (30D)
2.3M

From daily bars

Financials

Consensus estimates

The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.